SPEAKERS
Neil Bansal
CEO, SPS Health
Neil Bansal brings 15 years of healthcare services operating and investing experience to his role as chief executive officer of SPS Health. Prior to SPS, he served as an executive leading finance and growth strategy at a national long-term care pharmacy. Neil was previously a healthcare services–focused investor in New York City.
Neil earned his MBA from Wharton with a concentration in healthcare management and entrepreneurship and his bachelor’s degree from the Kelley School of Business at Indiana University.
He enjoys skiing, running, and Midwest lake life. He lives with his wife Natalie and three children, Auden, Elliott, and Valentina in Chicago.
Mark Parkinson
Principal, AHCA/NCAL
Mark Parkinson is the Principal of the American Health Care Association and the National Center for Assisted Living (AHCA/NCAL), which represents more than 14,000 nursing homes, assisted living communities, and intermediate care facilities for individuals with disabilities. Previously, Parkinson was the association’s President and CEO for 14 years. Prior to his role as President and CEO, Parkinson served as the 45th Governor of the State of Kansas. He was also the owner and operator of long term care facilities in Kansas and Missouri.
Since February 2025, Parkinson has served as CEO of Park Place, a comprehensive resource dedicated to supporting success in the long-term care profession.
Under Parkinson’s leadership, AHCA/NCAL focused on delivering policy solutions to the Hill and the Administration, with a special emphasis on quality care. During his tenure, AHCA/NCAL remained the largest association in long term care and enjoyed record membership.
Parkinson’s vision and leadership has brought him recognition. He was named a top lobbyist for 12 consecutive years (2013-2024) by The Hill, a leading Capitol Hill newspaper. Parkinson also had the distinction of being selected as one of the “100 Most Influential People in Healthcare” by Modern Healthcare in 2015, 2020, 2021, 2022, and 2023. Parkinson was named Top CEO in the small-employer category by The Washington Post 2019 Top Workplace survey, and Top Association CEO by CEO Update in 2013. Washingtonian selected Parkinson as one of Washington, DC’s 500 Most Influential People in 2022, 2023, and 2024. In 2024, Parkinson was named as the recipient of the McKnight’s Pinnacle Career Achievement Award and was awarded the American Association of Post-Acute Care Nursing LTPAC Lifetime Impact Award.
Matt Lewis
Political Commentator, Opinion Contributor for The Hill, and Author of “Filthy Rich Politicians”
Called a “first-rate talent” in The Washington Post and “super-smart” by John Heilemann, Matt K. Lewis is a center-right critic of American politics and pop culture. He is Opinion Contributor for the Hill and author of Filthy Rich Politicians.
Exclusively represented by Leading Authorities speakers bureau, Lewis dissects the day’s issues in conversation with other thinkers, authors, and newsmakers on his podcast, Matt Lewis and the News, and co-hosts The DMZ Show with liberal pundit Bill Scher. He has also been a contributor for Daily Beast, TheWeek.com and the Daily Caller. Previously, he served as a columnist for AOL’s Politics Daily, and before that as a blogger for Townhall.com.
As a journalist, Lewis has earned a reputation as an “independently minded” (Columbia Journalism Review) and “intellectually honest” commentator (Ben Adler, Newsweek). Named one of the “40 Best Conservative Columnists” byRightWingNews each year since 2013, he has been acknowledged as the 2012 “CPAC Blogger of the Year” by The American Conservative Union and one of the 50 “Pundits You Need to Pay Attention to Between Now and The Election” in 2011 by Business Insider. Additionally, the Young Conservatives Coalition’s selected Lewis as a recipient of their second annual “Buckley Award” in 2011. From 2021-2023, Matt served as a Fellow for Notre Dame University’s de Nicola Center for Ethics and Culture.
Matt’s work has also appeared in outlets such as GQ, The Wall Street Journal, The Washington Post, POLITICO, Roll Call, The Telegraph, The Independent, and the Guardian — and he has been quoted or cited by major media outlets including New York Magazine, the Washington Post, the New York Times, and the Associated Press. As a commentator, Matt has appeared on Fox News, CNN, MSNBC, C-SPAN, PBS NewsHour, ABC’s Nightline, CBS News’ Face the Nation, and HBO’s Real Time with Bill Maher, and has contributed to radio outlets including NPR and the BBC.
Andrew Busch
Consultant, Expert on Global Financial Markets
Andrew Busch is the former 1st Chief Market Intelligence Officer for the US government and economic futurist at AndrewBusch.com. For the CFTC, he was charged with improving and enhancing the government’s understanding of the markets and the economy. His job was to take all the news, information and data on the economy and markets; and filter it into condensed, easily understood research; then communicate it to the government and public.
Andy provided economic and market briefings to White House, US House, US Senate, the SEC, the Federal Reserve Board and the US Treasury staff on a wide range of issues including interest rates, inflation, China’s influence on trade, and the impact of technology on the economy.
Prior to joining the CFTC, Mr. Busch was CEO and founder of a boutique financial markets and policy research firm, Bering Productions, Inc (BPI). Before BPI, he was the Global Currency and Public Policy Strategist for Bank of Montreal (BMO) in Chicago. He is author of the book “World Event Trading” covering large crises, like infectious disease outbreaks and war, and their impact on the economy and markets.
Today, he’s a consultant and keynote speaker with a wide range of clients including chemicals, financial services, energy, real estate, manufacturing, construction and agriculture.
Theresa Carnegie
Member, Mintz
Theresa Carnegie combines her multilayered health care industry knowledge to advise clients through complex health care transactions and regulatory matters. She leads regulatory teams in both M&A transactions, venture capital, and private equity investments and has deep experience in contracting matters, complex due diligence reviews, fraud and abuse risks, licensing, and regulatory filings.
Theresa leverages extensive knowledge of the pharmaceutical supply chain to advise clients investing in the industry on structural considerations, corporate matters, regulatory requirements and compliance risks, and business challenges and opportunities.
Bill Roth
SVP, IntegriChain’s Consulting and Advisory Services
Bill is the SVP of IntegriChain’s Consulting Advisory Businesses including the well-known Blue Fin Group which he founded in 2001. Bill is an expert in commercialization for every form of pharmaceuticals working to develop holistic strategies to ensure that innovative science comes to market and patients have affordable access. The consulting businesses that Bill runs support over 450 manufacturers including all of the top 40 and spans all forms of products including Specialty, Orphan Rare, Cell and Gene, Vaccines, Biosimilars, and of course Primary Care Brand and Generic products.
Throughout his 30+ year he has been a serial entrepreneur and accomplished corporate employee functioning as a thought leader developing and executing new business models for startups and Fortune 100s in the pharmaceutical and healthcare industry. Bill is an accomplished consultant disciplined in strategy, business development, commercial operations, marketing, channel and patient services design, and the design and use of technology.
As a known futurist in the industry Bill has called most of the major tectonic shifts in the market. He has been publicized in dozens of industry publications for thought leadership and frequently cited by market researchers and analysts. He has been a frequent speaker at industry events and seminars. He was featured in the cover story of Entrepreneur Magazine in 2001, was a 2008 recipient of PharmaVOICE magazine’s “Top 100 most-inspiring people in Life Sciences” and a 2009 PM360’s “People to Watch”. In 2016, Bill was featured as the cover story in Pharmaceutical Commerce for his predictions of what the Life Sciences industry would look like out to 2030, which have proven to be highly accurate to date.
Albert Thigpen
Operating Advisor, Nautic Partners
Albert Thigpen is a 30 plus-year industry veteran in the pharmacy operations and PBM landscape. A pharmacist by training, he has held numerous C-Level and Senior level positions in the PBM, Pharmacy Operations, and Supply Chain industries; most notably at United Healthcare/OptumRx, LDI and Diplomat, Catamaran, and CVS Caremark.
Albert currently serves as an Operating Advisor to Nautic Partners advising on current and prospective portfolio companies. He is the Chairman of the Board at Empirx Health, a board member of SPS Health, and Pantherx Rare Specialty Pharmacy.